Please ensure Javascript is enabled for purposes of website accessibility

Senseonics begins US 180-day study of implantable monitor (access required)

The Germantown company that developed the only long-term implantable system for monitoring blood sugar has begun a clinical study to study its system when implanted for twice as long as is now allowed in the United States.

To purchase a reprint of this article, contact [email protected].